European countries are imposing a patchwork of tough restrictions that are impeding research.
Hoping to squeeze more products out of a sputtering drug pipeline, pharmaceutical makers are Aiming to exploit advances in molecular biology. That means changing everything from their corporate cultures to the nature of their university collaborations.
GE's Jeffrey Immelt sees high-tech firms dominating a slow-growth economy-and the biggest players becoming the biggest winners.
Some people are saddled with names they hate. But thanks to a new twist on a familiar technology, today's parents can avoid ghastly mistakes.
Comic strips for a quarter? A new twist on micropayments is raising the likelihood that you'll be able to pay tiny sums of money for small slivers of information.
Insights and opinions from our readers.
DNA-derived vaccine advances on MS.
Former El Al security head Isaac Yeffet on how technology fails air safety.
Powerful new imaging technologies pinpoint the molecular events involved in diseases, promising a safer alternative to biopsies.
Massachusetts General Hospital doctors lead a tour of what they hope will be the world's most efficient operating room.